Novartis news: Drug giant to pay $245M to settle antitrust case
The pharmaceutical company is reportedly paying $245 million to settle an antitrust case over a hypertension drug.
Read More
Novartis
Layoff anxiety is growing: Searches about job losses skyrocket across Triangle, US
Concerns about layoffs, including tech layoffs at firms with big presences in the Triangle, are on the rise, new data shared with WRAL TechWire shows.
Read More
Drug giant Novartis to close plant in Wilson where more than 240 people work
Drug giant Novartis says it will close a plant in Wilson that employs more than 200 people, but it’s not part of a global cost-cutting strategy. The plant is actually being kept open longer than planned, the company says.
Read More
Precision, Novartis ink potential $1.4B development deal
Durham-based Precision Biosciences has landed a new deal with Novartis that could be worth up to $1.4 billion. The NC Biotech Center has the story.
Read More
Novartis Gene Therapies is new name for gene therapy firm with growing RTP presence
Novartis has announced the renaming of its previously acquired AveXis gene therapy arm because of “the growing importance of gene therapy to building a leading, focused medicines company with advanced therapy platforms.”
Read More
Gene therapy firm to add 200 jobs, invest $60M in Durham county facility
North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.
Read More
Budding town, big company — the story and lasting impact of Seqirus in Holly Springs
Once considered a “bedroom community,” Novartis opened the doors for other businesses to come to Holly Springs and has helped shape it into the thriving life science hub it is today.
Read More
AT&T CEO says hiring Trump lawyer Michael Cohen ‘was a big mistake’
“AT&T hiring Michael Cohen as a political consultant was a big mistake,” the company’s CEO Randall Stephenson said Friday morning.
Read MoreGSK acquiring Novartis consumer healthcare division for $13B
GlaxoSmithKline is acquiring the Novartis f consumer healthcare division for $13 billion. The purchase gives Glaxo full control of products that include Voltaren for muscle pain, Senosdyne toothpaste, Panadol for headaches and other Novartis products.
Read More- 1
- 2
